Exascale Labs Holdings Inc. (XLAB) Stock Overview
Explore Exascale Labs Holdings Inc.’s financial performance, market position, analyst ratings, and future outlook.
Exascale Labs Holdings Inc. (XLAB)
Key Financials
Key Financials
Market Cap
50.1M
P/E Ratio
N/A
EPS (TTM)
$0.20
ROE
N/A
XLAB Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Exascale Labs Holdings Inc. (NASDAQ: XLAB) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Exascale Labs Holdings Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of XLAB on the NASDAQ shows an RSI of 29.90, suggesting the stock is in a an oversold condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.
Key metrics behind Exascale Labs Holdings Inc.'s NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 50.1M. Combined with our AI analysis, these give both institutional and retail investors a clear view of XLAB on the NASDAQ.